Invention Grant
- Patent Title: Nucleic acid construct for in vitro and in vivo gene expression
-
Application No.: US16956092Application Date: 2018-12-19
-
Publication No.: US11608504B2Publication Date: 2023-03-21
- Inventor: Margit Pedersen , Manos Papadakis
- Applicant: GLYCOM A/S
- Applicant Address: DK Hørsholm
- Assignee: GLYCOM A/S
- Current Assignee: GLYCOM A/S
- Current Assignee Address: DK Hørsholm
- Agency: Neal, Gerber & Eisenberg LLP
- Priority: DKPA201700737 20171221,DKPA201800173 20180418,DKPA201800231 20180524
- International Application: PCT/IB2018/060355 WO 20181219
- International Announcement: WO2019/123324 WO 20190627
- Main IPC: C12N15/70
- IPC: C12N15/70 ; C12N15/113 ; C12N15/11 ; C12N15/67
Abstract:
The present invention relates to the field of recombining production of biological molecules in host cells. The invention provides nucleic acid constructs that allow to modify expression of a desired gene using both in vitro and in vivo gene expression systems. The constructs can advantageously be used to produce a variety of biological molecules recombinantly in industrial scales, e.g. human milk oligosaccharides (HMO).
Public/Granted literature
- US20210102216A1 NUCLEIC ACID CONSTRUCT FOR IN VITRO AND IN VIVO GENE EXPRESSION Public/Granted day:2021-04-08
Information query
IPC分类:
